| Net income (loss) | 61.33M |
| Depreciation and amortization | |
| Equity compensation expense | 1.98M |
| Accretion of fair market value adjustment of debt | |
| Loan procurement amortization expense - early repayment of debt | |
| Other assets | -6.83M |
| Restricted cash | 404K |
| Accounts payable and accrued expenses | 17.56M |
| Other liabilities | 1.57M |
| Net cash provided by operating activities | 201.42M |
| Acquisitions, additions and improvements to storage facilities | |
| Proceeds from repayment of notes receivable | |
| (Increase) decrease in restricted cash | 970K |
| Net cash (used in) provided by investing activities | -472.13M |
| Revolving credit facility | 830M |
| Unsecured Term Loans | |
| Mortgage loans and notes payable | |
| Revolving credit facility | -830M |
| Unsecured Term Loans | |
| Mortgage loans and notes payable | |
| Proceeds from issuance of common shares, net | 136.15M |
| Exercise of stock options | 12.57M |
| Contributions from noncontrolling interests in subsidiaries | 4.45M |
| Distributions paid to shareholders | -111.47M |
| Distributions paid to noncontrolling interests in Operating Partnership | |
| Distributions paid to noncontrolling interests in subsidiaries | |
| Loan procurement costs | -2.47M |
| Net cash provided by (used in) financing activities | 295.22M |
| Decrease in cash and cash equivalents | 24.51M |
| Cash and cash equivalents at beginning of period | 62.87M |
| Cash and cash equivalents at end of period | 87.38M |
| Cash paid for interest, net of interest capitalized | 38.11M |
| Acquisition related contingent consideration | |
| Foreign currency translation adjustment | |
| Derivative valuation adjustment | |
| Mortgage loan assumption at fair value | 41.51M |